Clinical Laboratory Improvement Amendments of 1988 (CLIA); Virtual Access, Gynecologic Cytology Proficiency Testing (PT), Personnel Qualifications, and Other Changes
Key claim: CMS proposes to let most clinical labs remotely access test data under the original lab’s CLIA certificate, allow digital images for Pap-smear proficiency testing, and change who is qualified to work in labs, along with other reporting and enforcement updates.
Abstract
(Proposed Rule · Health and Human Services Department, Centers for Medicare & Medicaid Services) This proposed rule would amend the Clinical Laboratory Improvement Amendments of 1988 (CLIA) regulations to allow for virtual access under the CLIA certificate of the primary testing laboratory that generated the data, with the exception of the subspecialty of cytology, and the use of digital images for gynecologic cytology proficiency testing. This proposed rule also includes proposed changes to personnel qualification requirements and other proposed changes pertaining to SARS-CoV-2 reporting requirements, certificate requirements, test reporting requirements, enforcement requirements, public consultation requirements, and editorial and technical updates. These proposed updates aim to strengthen the Federal oversight of clinical laboratories and ensure accurate and reliable patient test results while adapting to modern technological capabilities and industry needs, including workforce shortages.
Why this matters
CLIA sets the baseline federal standards every clinical laboratory in the U.S. must meet, so modernizing virtual data access, cytology proficiency testing, and personnel qualifications would reshape day-to-day lab operations, remote work arrangements, and the pool of people qualified to perform testing. Because the rule is still proposed, labs, pathologists, and lab technologists have a comment window before any of these operational and workforce changes take effect.